Skip to search formSkip to main contentSkip to account menu

Hycamtin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Topotecan (TPT) is in clinical use as an antitumor agent, hycamtin™. Because of this, it requires both biologically and… 
2006
2006
The objective of this study was to study the efficacy and adverse effects of hycamtin for small-cell lung cancer treatment… 
2003
2003
OBJECTIVE To discuss the therapeutic effect and toxicity of second line Hycamtin for lung cancer patients. METHODS Ten of these… 
2002
2002
Objective To examine the effect of Hycamtin on two kinds of endometrial carcinoma cell lines, Ishikawa 3H12 and HEC 1A. Methods… 
2001
2001
The response of ovarian serous papillary adenocarcinomas to various cytotoxic drugs was examined using the (3-(4,5… 
2001
2001
BACKGROUND Since no effective therapeutic approach is yet known for metastatic renal cell carcinoma (RCC), we analyzed the… 
Highly Cited
1999
Highly Cited
1999
Highly Cited
1998
Highly Cited
1998
Purpose: We have previously reported that DX-8951f, a water-soluble and nonprodrug camptothecin (CPT) derivative, exhibits both… 
1998
1998
Hycamtin is a camptothecin anticancer analogue containing a dimethylaminomethyl substituent at position 9 and a hydroxy…